Provided by Tiger Trade Technology Pte. Ltd.

Xencor

12.45
-0.0600-0.48%
Pre-market: 12.470.0200+0.16%04:57 EDT
Volume:635.51K
Turnover:7.86M
Market Cap:913.07M
PE:-10.04
High:12.61
Open:12.54
Low:12.00
Close:12.51
52wk High:18.69
52wk Low:6.92
Shares:73.34M
Float Shares:64.45M
Volume Ratio:0.77
T/O Rate:0.99%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2400
EPS(LYR):-1.2400
ROE:-14.07%
ROA:-12.14%
PB:1.44
PE(LYR):-10.04

Loading ...

Top Xencor Executive Quietly Cashes Out a Chunk of Company Stock

TIPRANKS
·
Apr 14

Xencor Shares Fall After JPMorgan Downgrade

MT Newswires Live
·
Mar 25

Xencor Cut to Neutral From Overweight by JP Morgan

Dow Jones
·
Mar 24

JPMorgan Downgrades Xencor to Neutral From Overweight, Adjusts PT to $13 From $18

MT Newswires Live
·
Mar 24

Analysts Offer Insights on Healthcare Companies: Moderna (MRNA) and Xencor (XNCR)

TIPRANKS
·
Mar 24

Xencor downgraded to Neutral from Overweight at JPMorgan

TIPRANKS
·
Mar 24

Xencor Inc : JP Morgan Cuts to Neutral From Overweight; Cuts Target Price to $13 From $18

THOMSON REUTERS
·
Mar 24

U.S. RESEARCH ROUNDUP-Apogee Therapeutics, Insmed, Sunoco

Reuters
·
Mar 24

Xencor’s Lung Cancer Trial Halted: What the Vudalimab Update Means for XNCR Investors

TIPRANKS
·
Mar 14

Xencor, Genentech to End Protein Therapeutics Collaboration

TIPRANKS
·
Mar 10

Genentech Terminates Collaboration Agreement With Xencor

Dow Jones
·
Mar 10

Xencor reports receipt of notice of termination of license agreement from Roche

TIPRANKS
·
Mar 10

Xencor (XNCR) Receives a Buy from Wedbush

TIPRANKS
·
Mar 05

Analysts Offer Insights on Healthcare Companies: Stevanato Group (STVN), Stryker (SYK) and Xencor (XNCR)

TIPRANKS
·
Mar 05

Xencor: Buy Rating Reaffirmed on Pipeline Momentum Despite Ultomiris Royalty Headwind

TIPRANKS
·
Mar 05

Xencor Says Licensee Will Stop Paying U.S. Royalties, Lowers Cash Outlook

Dow Jones
·
Mar 05

Xencor Updates Outlook Amid Ultomiris Royalty Dispute

TIPRANKS
·
Mar 05

Xencor expects cash to fund operations into mid-2028

TIPRANKS
·
Mar 05

Xencor forecasts $380 million to $400 million cash at end-2026 and runway into mid-2028

Reuters
·
Mar 05

Xencor Inc - Updates Year-End Cash Guidance and Adjusted Oper Runway Estimate Into Mid-2028

THOMSON REUTERS
·
Mar 05